Butoconazole
- Level
- Commodity
- Parent
- 51302300
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51302328This classification denotes an antifungal agent with the molecular formula C19H17Cl3N2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0Q771797PH, chemically known as 1h-imidazole, 1-(4-(4-chlorophenyl)-2-((2,6-dichlorophenyl)thio)butyl)-, nitrate but generally known as butoconazole, which bears US NIH Compound Identifier 47472. Butoconazole most often comes in base and nitrate forms. European Medicines Agency schedules Butoconazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06026MIG. The term BUTOCONAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, No. 10 1979, List 19). World Health Organization schedules butoconazole in its Anatomical Therapeutic Chemical (ATC) Classification. BUTOCONAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule butoconazole under HS 29332990 and SITC 51573. As of Q4 2014, BUTOCONAZOLE remains the US FDA Preferred Term for this commodity. Butoconazole bears US NLM identifiers UMLS ID C0054259 and NCI Concept Code C79927. SMILES: CLC1C(SC(CCC2CCC(CL)CC2)CN2CCNC2)C(CL)CCC1.
Same parent
Under 51302300 · 42Activities that produce or sell this
KBLI · 9Inherited from family 51300000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.